Business description
Gerresheimer is a leading global partner to the pharma and healthcare industry. With its specialty glass and plastic products, the company contributes to health and well-being. It has worldwide operations and about 10,000 employees manufacture the products in local markets, close to its customers. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
Management board & Supervisory board
| CEO |
| Dietmar Siemssen |
| Management board |
| Dr. Bernd Metzner, Dr. Lukas Burkhardt |
| Supervisory board |
| Dr. Axel Herberg, Francesco Grioli, Andrea Abt, Dr. Karin Louise Dorrepaal, Dr. Peter Noé, Katja Schnitzler, Markus Rocholz, Paul Schilling, Udo J. Vetter, Prof. Dr. Annete G. Köhler, Marlis Mergenthal, Robert Fröhler |
Company data
| Name: |
Gerresheimer AG |
| Address: |
Klaus-Bungert-Straße 4,D-40468 Düsseldorf |
| Phone: |
+49-211-6181-00 |
| Fax: |
+49-211-6181-295 |
| E-mail: |
info@gerresheimer.com
|
| Internet: |
www.gerresheimer.com |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
30/11 |
| Free Float: |
43.29% |
| IPO date: |
11/06/2007 |
